Application 206729
- Type
- ANDA
- Sponsor
- MICRO LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | 2.5MG | No | No |
| 002 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | 5MG | No | No |
| 003 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | 10MG | No | No |
| 004 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | 20MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| nebivolol | NEBIVOLOL HYDROCHLORIDE | AvKARE | 1ce89dc5-018d-db40-e063-6294a90a9722 | 2026-01-16 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| nebivolol | NEBIVOLOL HYDROCHLORIDE | Apnar Pharma LP | 3f5766c0-e1fa-4805-a32c-523182310ad5 | 2025-02-14 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| Bystolic | NEBIVOLOL HYDROCHLORIDE | Allergan, Inc. | 8b8ad213-1dc8-454e-a524-075685c0e1a8 | 2024-08-01 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| nebivolol | NEBIVOLOL HYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | cb47560d-9e35-4b0f-b12b-6ea478684a5b | 2023-08-01 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| Nebivolol Hydrochloride | NEBIVOLOL HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | b1762bbb-b5be-48a7-8101-bb736f28845a | 2023-07-11 | Warnings, Adverse reactions | Nebivolol Hydrochloride NEBIVOLOL HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.